Anti-Microbial Savior BioteQ Co., Ltd. (TPEX: 6864)
Health Care · Biotechnology · TW
NT$48.70
-2.60% today · -46.3% 1Y
Anti-Microbial Savior BioteQ Co., Ltd. (TPEX: 6864) operates in the Biotechnology industry within the Health Care sector. The company is valued at $56.85M and employs 15 people.
Over the last twelve months the share price has lost 46.3%, trading between 39.55 and 96.20.
Tweenvest scores Anti-Microbial Savior BioteQ Co., Ltd. across four factors: quality 40/100, value 30/100, growth 85/100. Its strongest factor is growth.
6864 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $56.85M
- Revenue (TTM)
- $39.54K
- P/E
- —
- EPS
- -2.54
- Dividend yield
- —
- Beta (5Y)
- -0.11
- 52-week high
- NT$96.20
- 52-week low
- NT$39.55
- Avg volume (3M)
- —
- Shares outstanding
- 37.88M
- Employees
- 15
- Next earnings
- —
About Anti-Microbial Savior BioteQ Co., Ltd.
Established in 2018, Anti-Microbial Savior BioteQ Co., Ltd. is a Kaohsiung, Taiwan-based enterprise primarily engaged in the research and development of medicinal drugs.
- ISIN
- TW0006864002
- Founded
- 2018
- Listed since
- Dec 29, 2021
- Exchange
- Taipei Exchange
- Currency
- TWD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Adaptin Bio, Inc.OTCPK: APTN | $57.89M | $— | — |
| Biosino Bio-Technology and Science IncorporationSEHK: 8247 | $57.71M | HK$3.13 | -0.32% |
| B&K Corporation LimitedSEHK: 2396 | $57.42M | HK$3.83 | -8.70% |
| Caribou Biosciences, Inc.NasdaqGS: CRBU | $57.12M | $0.53 | -4.86% |
| Alps Group IncNasdaqGM: ALPS | $56.58M | $0.34 | -8.11% |
| Xilio Therapeutics, Inc.NasdaqCM: XLO | $56.26M | $8.55 | -5.52% |
| Boundless Bio, Inc.NasdaqGS: BOLD | $55.27M | $2.43 | +5.19% |
| Synthaverse S.A.WSE: SVE | $55.01M | zł2.81 | -0.88% |
Figures last refreshed Oct 18, 2026.